New CETSA® Publication
Quantitative target engagement of RIPK1 in human whole blood via the cellular thermal shift assay for potential pre-clinical and clinical applications In a recent collaboration between AbbVie Chemical...
Unlocking Proteomics: Pelago Bioscience’s HUPO Award-Winning CETSA® approach
Stockholm, Sweden 12 September 2023 Pelago Bioscience proudly receives the HUPO Science and Technology Award, celebrating our pioneering work in CETSA (Cellular Thermal Shift Assay) and the Pelago tea...
Pelago Bioscience Featured in Top Ten Most Popular Drug Hunter Resources of 2023
We’re delighted to share that our commitment to advancing Drug Discovery has earned us a spot in the “Top Ten Most Popular Drug Hunter Resources of 2023.” The insightful article, “Drug Target Identifi...
A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery
We are thrilled to share our latest publication in the journal “ACS Medicinal Chemistry Letters” titled – A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery. In this study, we hi...